FDA NDC Directory · JSON-LD · Markdown

Sucralfate

NDC 17856-0306 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerATLANTIC BIOLOGICALS CORP.
Marketing categoryAbbreviated NDA (generic) · App ANDA211884
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSUCRALFATE (1 g/10mL)
Marketing started20220315
Package count1

External sources

Source: openFDA. Public-domain (CC0).